Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia

被引:20
作者
Keramat, Fariba [1 ,2 ]
Basir, Hamid Reza Ghasemi [3 ]
Abdoli, Elham [2 ]
Aghdam, Arghavan Shafiei [4 ]
Poorolajal, Jalal [5 ]
机构
[1] Hamadan Univ Med Sci, Brucellosis Res Ctr, Hamadan, Iran
[2] Hamadan Univ Med Sci, Sina Hosp, Dept Infect Dis, Hamadan, Iran
[3] Hamadan Univ Med Sci, Sch Med, Dept Pathol, Hamadan, Iran
[4] Hamadan Univ Med Sci, Sch Med, Hamadan, Iran
[5] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Res Ctr Hlth Sci, Hamadan, Iran
关键词
procalcitonin; community-acquired pneumonia; C-reactive protein; CURB-65; MANAGEMENT; INFECTION; BIOMARKER; SEVERITY; ADULTS; RISK;
D O I
10.2147/IJGM.S165190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The concentration of diagnostic markers such as inflammatory biomarkers including procalcitonin (PCT) and C-reactive protein (CRP) increases in bacterial infections. The aim of this study was to compare serum PCT and CRP levels with CURB-65 ranking, in the patients with community-acquired pneumonia (CAP). Patients and methods: In a cross-sectional study, 93 hospitalized patients with a definite diagnosis of CAP, considering inclusion and exclusion criteria, were enrolled. Serum PCT and CRP levels and their relations with CURB-65 criteria were assessed. Results: The mean serum levels of PCT and CRP were 3.64 +/- 12.32 ng/mL and 75.01 +/- 51.93 mg/L, respectively. There was a statistically significant association between CURB-65 criteria and serum levels of PCT (P=0.0001) and CRP (P=0.007), which means that the concentration of these two inflammatory biomarkers increased with an increase in the score of CURB-65 criteria. Moreover, there was a statistically significant association between the serum level of PCT and the outcomes of the disease (P<0.001). Conclusion: According to the results, the serum level of PCT or CRP is a strong prognostic factor for evaluating severity of CAP and is a suitable factor for the CURB-65 criteria in the decision making of whether a patient with CAP in the ICU should be admitted.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 19 条
[1]   Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD [J].
Bafadhel, Mona ;
Clark, Tristan W. ;
Reid, Carlene ;
Medina, Marie-jo ;
Batham, Sally ;
Barer, Michael R. ;
Nicholson, Karl G. ;
Brightling, Christopher E. .
CHEST, 2011, 139 (06) :1410-1418
[2]  
Berg P, 2012, DAN MED J, V59
[3]   Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia [J].
Boussekey, N ;
Leroy, O ;
Alfandari, S ;
Devos, P ;
Georges, H ;
Guery, B .
INTENSIVE CARE MEDICINE, 2006, 32 (03) :469-472
[4]   Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia [J].
Christ-Crain, Mirjam ;
Opal, Steven M. .
CRITICAL CARE, 2010, 14 (01)
[5]   Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough [J].
Flanders, SA ;
Stein, J ;
Shochat, G ;
Sellers, K ;
Holland, M ;
Maselli, J ;
Drew, WL ;
Reingold, AL ;
Gonzales, R .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (08) :529-535
[6]   Procalcitonin as a Biomarker in Respiratory Tract Infection [J].
Gilbert, David N. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 :S346-S350
[7]   Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia [J].
Huang, David T. ;
Weissfeld, Lisa A. ;
Kellum, John A. ;
Yeally, Donald M. ;
Kong, Lan ;
Martino, Michael ;
Angus, Derek C. .
ANNALS OF EMERGENCY MEDICINE, 2008, 52 (01) :48-58
[8]   Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia [J].
Kim, Ji Hye ;
Seo, Joo Wan ;
Mok, Jeong Ha ;
Kim, Mi Hyun ;
Cho, Woo Hyun ;
Lee, Kwangha ;
Kim, Ki Uk ;
Jeon, Doosoo ;
Park, Hye-Kyung ;
Kim, Yun Seong ;
Kim, Hyung Hoi ;
Lee, Min Ki .
TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 74 (05) :207-214
[9]   Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes [J].
Krueger, S. ;
Ewig, S. ;
Marre, R. ;
Papassotiriou, J. ;
Richter, K. ;
von Baum, H. ;
Suttorp, N. ;
Welte, T. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :349-355
[10]   Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study [J].
Lim, WS ;
van der Eerden, MM ;
Laing, R ;
Boersma, WG ;
Karalus, N ;
Town, GI ;
Lewis, SA ;
Macfarlane, JT .
THORAX, 2003, 58 (05) :377-382